Sensitivity analyses of the change in FVC in a phase 3 trial of pirfenidone for idiopathic pulmonary fibrosis

David J. Lederer, Williamson Z. Bradford, Elizabeth A. Fagan, Ian Glaspole, Marilyn K. Glassberg, Kenneth F. Glasscock, David Kardatzke, Talmadge E. King, Lisa H. Lancaster, Steven D. Nathan, Carlos A. Pereira, Steven A. Sahn, Jeffrey J. Swigris, Paul W. Noble

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint Dive into the research topics of 'Sensitivity analyses of the change in FVC in a phase 3 trial of pirfenidone for idiopathic pulmonary fibrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences